Abstract
Neurological disorders associated with glutamic acid decarboxylase (GAD65) antibodies represent a relatively new field of research in the modern clinical neurology and are of great theoretical and practical interest. High titer of anti-GAD65 antibodies is a highly sensitive, though not always specific, marker of the autoimmune disorders of the central nervous system (CNS). Literature review and authors' clinical observations of the phenotypic heterogeneity of GAD65-associated disorders are presented in the paper.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Kalamkaryan, A.A., Mordovtsev, V.N., and Trofimova, L.Ya., Klinicheskaya dermatologiya. Redkie i atipichnye dermatozy (Clinical Dermatology: Rare and Atypical Dermatoses), Yerevan: Aiastan, 1989.
Krasnov, M.Yu., Timerbaeva, S.L., and Illarioshkin, S.N., Genetics of hereditary forms of dystonia, Ann. Klin. Eksp. Nevrol., 2013, no. 2, p. 55.
Malmberg, S.A., Dadali, E.L., Zhumakhanov, D.B., et al., Stiff-person syndrome with early onset in infancy, Nervno-Myshechnye Bolezni, 2015, no. 2, p. 38.
Alexopoulos, H. and Dalakas, M.C., A clinical update on the immunopathogenesis of Stiff Person Syndrome, Eur. J. Clin. Invest., 2010, vol. 40, no. 11, p. 1018.
Ariño, H., Gresa-Arribas, N., Blanco, Y., et al., Cerebellar ataxia and glutamic acid decarboxylase antibodies: immulologic profile and long-term effect of immunotherapy, JAMA Neurol., 2014, vol. 71, no. 8, p. 1009.
Boronat, A., Sabater, L., Saiz, A., et al., GABAB receptor antibodies in limbic encephalitis and anti-GAD–associated neurologic disorders, Neurology, 2011, vol. 76, no. 9, p. 795.
Braun, J. and Sieper, J., Ankylosing spondylitis, Lancet, 2007, vol. 369, no. 9570, p. 1379.
Chen, Y.-T., Glycogen storage diseases, in The Metabolic and Molecular Bases of Inherited Disease, Scriver, C.R., Beaudet, A.L., Sly, W.S., and Valle, D., Eds., New York: McGraw-Hill, 2001, vol. 1, p. 1537.
Dayalu, P. and Teener, J.W., Stiff Person syndrome and other anti-GAD-associated neurologic disorders, Semin. Neurol., 2012, vol. 32, no. 5, p. 544.
Drost, G., Verrips, A., Hooijkaas, H., et al., Glutamic acid decarboxylase antibodies in Satoyoshi syndrome, Ann. Neurol., 2004, vol. 55, no. 3, p. 450.
Ehlayel, M.S. and Lacassie, Y., Satoyoshi syndrome: an unusual postnatal multisystemic disorder, Am. J. Med. Genet., 1995, vol. 57, no. 4, p. 620.
Graus, F., Delattre, J.Y., Antoine, J.C., et al., Recommended diagnostic criteria for paraneoplastic neurological syndromes, J. Neurol., Neurosurg. Psychiatry, 2004, vol. 75, no. 8, p. 1135.
Gultekin, S.H., Recent developments in paraneoplastic disorders of the nervous system, Surg. Pathol. Clin., 2015, vol. 8, no. 1, p. 89.
Hadjivassiliou, M., Sanders, D.S., Woodroofe, N., et al., Gluten ataxia, Cerebellum, 2008, vol. 7, no. 3, p. 494.
Honnorat, J., Saiz, A., Giometto, B., et al., Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients, Arch. Neurol., 2001, vol. 58, no. 2, p. 225.
Kono, S., Miyajima, H., Sugimoto, M., et al., Stiffperson syndrome associated with cerebellar ataxia and high glutamic acid decarboxylase antibody titer, Intern. Med., 2001, vol. 40, no. 9, p. 968.
Kuchling, J. and Shababi-Klein, J., Nümann, A., et al., GAD antibody-associated late-onset cerebellar ataxia in two female siblings, Case Rep. Neurol., 2014, vol. 6, no. 3, p. 264.
Rakocevic, G. and Floeter, M.K., Autoimmune stiff person syndrome and related myelopathies: understanding of electrophysiological and immunological processes, Muscle Nerve, 2012, vol. 45, no. 5, p. 623.
Rüegg, S.J., Steck, A.J., and Fuhr, P., Levetiracetam improves paroxysmal symptoms in a patient with stiffperson syndrome, Neurology, 2004, vol. 62, no. 2, p. 338.
Saiz, A., Blanco, Y., Sabater, L., et al., Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association, Brain, 2008, vol. 131, p. 2553.
Sharma, B., Nagpal, K., Prakash, S., et al., Anti-GAD negative stiff person syndrome with a favorable response to intravenous methylprednisolone: an experience over evidence, Neurol. India, 2014, vol. 62, no. 1, p. 76.
Ueno, S., Miyamoto, N., Shimura, H., et al., Successful immune moderation treatment for progressive encephalomyelitis with rigidity and myoclonus, Intern. Med., 2015, vol. 54, no. 2, p. 219.
Vulliemoz, S., Vanini, G., Truffert, A., et al., Epilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies, BMJ Case Rep., 2009, vol. 2009, p. bcr09.2008.0977.
Wenninger, S. and Schoser, B., The spectrum of neuromyotonia: clinics, therapy and outcome, Fortschr. Neurol. Psychiatr., 2015, vol. 83, no. 8, p. 457.
Wu, Y., Weber, J.L., Vladutiu, G.D., and Tarnopolsky, M.A., Six novel mutations in the myophosphorylase gene in patients with McArdle disease and a family with pseudo-dominant inheritance pattern, Mol. Genet. Metab., 2011, vol. 104, no. 4, p. 587.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © M.Yu. Krasnov, E.V. Pavlov, M.V. Ershova, S.L. Timerbaeva, S.N. Illarioshkin, 2015, published in Annaly Klinicheskoi i Eksperimental’noi Nevrologii, 2015, Vol. 9, No. 4, pp. 37–48.
Rights and permissions
About this article
Cite this article
Krasnov, M.Y., Pavlov, E.V., Ershova, M.V. et al. Phenotypic heterogeneity of neurological disorders associated with glutamic acid decarboxylase antibodies. Hum Physiol 42, 874–878 (2016). https://doi.org/10.1134/S0362119716080089
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0362119716080089